These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21130495)

  • 21. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.
    Calin GA; Ferracin M; Cimmino A; Di Leva G; Shimizu M; Wojcik SE; Iorio MV; Visone R; Sever NI; Fabbri M; Iuliano R; Palumbo T; Pichiorri F; Roldo C; Garzon R; Sevignani C; Rassenti L; Alder H; Volinia S; Liu CG; Kipps TJ; Negrini M; Croce CM
    N Engl J Med; 2005 Oct; 353(17):1793-801. PubMed ID: 16251535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival.
    Rossi S; Shimizu M; Barbarotto E; Nicoloso MS; Dimitri F; Sampath D; Fabbri M; Lerner S; Barron LL; Rassenti LZ; Jiang L; Xiao L; Hu J; Secchiero P; Zauli G; Volinia S; Negrini M; Wierda W; Kipps TJ; Plunkett W; Coombes KR; Abruzzo LV; Keating MJ; Calin GA
    Blood; 2010 Aug; 116(6):945-52. PubMed ID: 20393129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 98% IGHV gene identity is the optimal cutoff to dichotomize the prognosis of Chinese patients with chronic lymphocytic leukemia.
    Shi K; Sun Q; Qiao C; Zhu H; Wang L; Wu J; Wang L; Fu J; Young KH; Fan L; Xia Y; Xu W; Li J
    Cancer Med; 2020 Feb; 9(3):999-1007. PubMed ID: 31849198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of novel sequence variations in microRNAs in chronic lymphocytic leukemia.
    Kminkova J; Mraz M; Zaprazna K; Navrkalova V; Tichy B; Plevova K; Malcikova J; Cerna K; Rausch T; Benes V; Brychtova Y; Doubek M; Mayer J; Pospisilova S
    Carcinogenesis; 2014 May; 35(5):992-1002. PubMed ID: 24306027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated miR-20b-5p expression in peripheral blood mononuclear cells: A novel, independent molecular biomarker of favorable prognosis in chronic lymphocytic leukemia.
    Papageorgiou SG; Kontos CK; Tsiakanikas P; Stavroulaki G; Bouchla A; Vasilatou D; Bazani E; Lazarakou A; Scorilas A; Pappa V
    Leuk Res; 2018 Jul; 70():1-7. PubMed ID: 29715621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating microRNA-192 as a diagnostic biomarker in human chronic lymphocytic leukemia.
    Fathullahzadeh S; Mirzaei H; Honardoost MA; Sahebkar A; Salehi M
    Cancer Gene Ther; 2016 Oct; 23(10):327-332. PubMed ID: 27659777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.
    Wiestner A; Rosenwald A; Barry TS; Wright G; Davis RE; Henrickson SE; Zhao H; Ibbotson RE; Orchard JA; Davis Z; Stetler-Stevenson M; Raffeld M; Arthur DC; Marti GE; Wilson WH; Hamblin TJ; Oscier DG; Staudt LM
    Blood; 2003 Jun; 101(12):4944-51. PubMed ID: 12595313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia.
    Pallasch CP; Patz M; Park YJ; Hagist S; Eggle D; Claus R; Debey-Pascher S; Schulz A; Frenzel LP; Claasen J; Kutsch N; Krause G; Mayr C; Rosenwald A; Plass C; Schultze JL; Hallek M; Wendtner CM
    Blood; 2009 Oct; 114(15):3255-64. PubMed ID: 19692702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1.
    Mraz M; Chen L; Rassenti LZ; Ghia EM; Li H; Jepsen K; Smith EN; Messer K; Frazer KA; Kipps TJ
    Blood; 2014 Jul; 124(1):84-95. PubMed ID: 24787006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of MiR-15a and MiR-16-1 as prognostic biomarkers in chronic lymphocytic leukemia.
    Braga TV; Evangelista FCG; Gomes LC; Araújo SSDS; Carvalho MDG; Sabino AP
    Biomed Pharmacother; 2017 Aug; 92():864-869. PubMed ID: 28599250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ON 01910.Na is selectively cytotoxic for chronic lymphocytic leukemia cells through a dual mechanism of action involving PI3K/AKT inhibition and induction of oxidative stress.
    Chapman CM; Sun X; Roschewski M; Aue G; Farooqui M; Stennett L; Gibellini F; Arthur D; Pérez-Galán P; Wiestner A
    Clin Cancer Res; 2012 Apr; 18(7):1979-91. PubMed ID: 22351695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia.
    Maura F; Cutrona G; Mosca L; Matis S; Lionetti M; Fabris S; Agnelli L; Colombo M; Massucco C; Ferracin M; Zagatti B; Reverberi D; Gentile M; Recchia AG; Bossio S; Rossi D; Gaidano G; Molica S; Cortelezzi A; Di Raimondo F; Negrini M; Tassone P; Morabito F; Ferrarini M; Neri A
    Leuk Lymphoma; 2015; 56(11):3150-8. PubMed ID: 25860243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitors.
    Sharma S; Pavlasova GM; Seda V; Cerna KA; Vojackova E; Filip D; Ondrisova L; Sandova V; Kostalova L; Zeni PF; Borsky M; Oppelt J; Liskova K; Kren L; Janikova A; Pospisilova S; Fernandes SM; Shehata M; Rassenti LZ; Jaeger U; Doubek M; Davids MS; Brown JR; Mayer J; Kipps TJ; Mraz M
    Blood; 2021 May; 137(18):2481-2494. PubMed ID: 33171493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression and Prognostic Value of MiR-155 in Patients with Chronic Lymphocytic Leukemia].
    Wang F; Xu W; Gu WY; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):34-39. PubMed ID: 32027250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-29c down-regulation is associated with disease aggressiveness and poor survival in Chinese patients with chronic lymphocytic leukemia.
    Zhou K; Yu Z; Yi S; Li Z; An G; Zou D; Qi J; Zhao Y; Qiu L
    Leuk Lymphoma; 2014 Jul; 55(7):1544-50. PubMed ID: 24138306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-223 expression is uniformly down-regulated in B cell lymphoproliferative disorders and is associated with poor survival in patients with chronic lymphocytic leukemia.
    Zhou K; Yi S; Yu Z; Li Z; Wang Y; Zou D; Qi J; Zhao Y; Qiu L
    Leuk Lymphoma; 2012 Jun; 53(6):1155-61. PubMed ID: 22145958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL.
    Vasyutina E; Boucas JM; Bloehdorn J; Aszyk C; Crispatzu G; Stiefelhagen M; Breuer A; Mayer P; Lengerke C; Döhner H; Beutner D; Rosenwald A; Stilgenbauer S; Hallek M; Benner A; Herling M
    Leukemia; 2015 Oct; 29(10):2003-14. PubMed ID: 25936528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IGHV3-21 gene usage is associated with high TCL1 expression in chronic lymphocytic leukemia.
    Mansouri MR; Sevov M; Aleskog A; Jondal M; Merup M; Sundström C; Osorio L; Rosenquist R
    Eur J Haematol; 2010 Feb; 84(2):109-16. PubMed ID: 19889012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNAs and B cell receptor signaling in chronic lymphocytic leukemia.
    Mraz M; Kipps TJ
    Leuk Lymphoma; 2013 Aug; 54(8):1836-9. PubMed ID: 23597135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia.
    Cui B; Chen L; Zhang S; Mraz M; Fecteau JF; Yu J; Ghia EM; Zhang L; Bao L; Rassenti LZ; Messer K; Calin GA; Croce CM; Kipps TJ
    Blood; 2014 Jul; 124(4):546-54. PubMed ID: 24914134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.